Churchill Capital Corp X/Cayman 8-K

What Happened
Churchill Capital Corp X (CCCX) announced that its shareholders approved the proposed business combination with ColdQuanta, Inc. (d/b/a Infleqtion) at an extraordinary general meeting held February 12, 2026. The S-4 (Form S-4 No. 333-295282), including the definitive proxy/prospectus, was declared effective January 23, 2026. At the meeting (record date Jan 13, 2026) holders representing ~46.629% of voting power were present and a quorum was established. Shareholders approved the Business Combination and related proposals (domestication, organizational documents, stock issuance, incentive plans, ESPP, and director elections). Churchill expects to domesticate to Delaware, rename the continuing company “Infleqtion, Inc.” and seek NYSE listing under the ticker “INFQ,” subject to closing conditions.

Key Details

• Vote totals for the Business Combination: For 22,111,101; Against 2,140,329; Abstained 18,737.
• Redemption activity: 37,821 Class A shares (0.09% of Class A) were redeemed, removing $388,453.90 ($10.27/share) from the trust.
• Cash to be delivered to Infleqtion at close: approximately $551.4 million gross (≈ $424.8M from the trust account + $126.5M from previously announced private placement).
• Effective next steps: domestication to Delaware (change of jurisdiction and name to Infleqtion, Inc.) and application to list post-combination common stock on the NYSE as "INFQ"; closing remains subject to customary conditions, including satisfaction or waiver of the listing requirement.

Why It Matters
The approvals clear the principal shareholder hurdles for the SPAC merger, enabling the combined company to proceed toward closing and to become a publicly listed company (subject to remaining conditions). Investors should note the material financing being delivered to Infleqtion (~$551M) that will fund its operations and growth plans, but also that closing is conditional (notably a listing requirement) and the filing includes extensive forward-looking statements and risk factors. The redemption amount was minimal, so the trust retains most proceeds; however, final outcomes depend on satisfying the Merger Agreement’s closing conditions and regulatory/listing approvals.